ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price rose 5.3% during trading on Thursday . The stock traded as high as $0.42 and last traded at $0.40. Approximately 439,255 shares traded hands during mid-day trading, an increase of 2,061% from the average daily volume of 20,327 shares. The stock had previously closed at $0.38.
ImmunoPrecise Antibodies Trading Up 0.8 %
The company has a fifty day moving average of $0.47 and a two-hundred day moving average of $0.72.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Insider Buying Explained: What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Why Are These Companies Considered Blue Chips?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
